Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative

Details for Australian Patent Application No. 2004289086 (hide)

Owner Sanofi-Aventis

Inventors Saslawski, Olivier; Breul, Thierry; Gautier, Jean Claude

Agent Davies Collison Cave

Pub. Number AU-A-2004289086

PCT Pub. Number WO2005/046690

Priority 0313259 10.11.03 FR

Filing date 9 November 2004

Wipo publication date 26 May 2005

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/046690 Priority application(s): WO2005/046690

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289088-Low-dose tablets having a network of polymers

2004289083-Use of glucosidase inhibitors for therapy of mucovisidosis